Sinoma Science & TechnologyLtd Valuation
Is 002080 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 002080 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 002080 (CN¥13.12) is trading above our estimate of fair value (CN¥6.68)
Significantly Below Fair Value: 002080 is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 002080?
Key metric: As 002080 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is 002080's PE Ratio? | |
|---|---|
| PE Ratio | 19.6x |
| Earnings | CN¥1.13b |
| Market Cap | CN¥22.17b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.9x |
| Enterprise Value/EBITDA | 15.4x |
| PEG Ratio | 0.6x |
Price to Earnings Ratio vs Peers
How does 002080's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 31.3x | ||
600143 Kingfa Sci. & Tech | 43.1x | 51.2% | CN¥22.4b |
000683 Inner Mongolia Yuan Xing Energy | 12.3x | 23.7% | CN¥21.3b |
300390 Canmax Technologies | 28x | 35.9% | CN¥21.7b |
603650 Red Avenue New Materials Group | 42x | 21.3% | CN¥21.2b |
002080 Sinoma Science & TechnologyLtd | 19.6x | 33.7% | CN¥22.2b |
Price-To-Earnings vs Peers: 002080 is good value based on its Price-To-Earnings Ratio (19.6x) compared to the peer average (31.3x).
Price to Earnings Ratio vs Industry
How does 002080's PE Ratio compare vs other companies in the CN Chemicals Industry?
| 0 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|
| 0 Companies | Estimated Growth | Market Cap |
|---|
Price-To-Earnings vs Industry: 002080 is good value based on its Price-To-Earnings Ratio (19.6x) compared to the CN Chemicals industry average (35.7x).
Price to Earnings Ratio vs Fair Ratio
What is 002080's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 19.6x |
| Fair PE Ratio | 28.8x |
Price-To-Earnings vs Fair Ratio: 002080 is good value based on its Price-To-Earnings Ratio (19.6x) compared to the estimated Fair Price-To-Earnings Ratio (28.8x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | CN¥13.12 | CN¥12.33 -6.0% | 17.4% | CN¥15.20 | CN¥9.23 | n/a | 4 |
| Nov ’25 | CN¥12.71 | CN¥12.33 -3.0% | 17.4% | CN¥15.20 | CN¥9.23 | n/a | 4 |
| Oct ’25 | CN¥12.77 | CN¥11.69 -8.5% | 11.0% | CN¥13.00 | CN¥9.23 | n/a | 5 |
| Sep ’25 | CN¥9.97 | CN¥11.69 +17.2% | 11.0% | CN¥13.00 | CN¥9.23 | n/a | 5 |
| Aug ’25 | CN¥11.35 | CN¥22.58 +98.9% | 14.6% | CN¥27.89 | CN¥19.00 | n/a | 4 |
| Jul ’25 | CN¥13.02 | CN¥23.26 +78.7% | 13.9% | CN¥27.89 | CN¥19.00 | n/a | 5 |
| Jun ’25 | CN¥14.99 | CN¥23.26 +55.2% | 13.9% | CN¥27.89 | CN¥19.00 | n/a | 5 |
| May ’25 | CN¥15.52 | CN¥23.26 +49.9% | 13.9% | CN¥27.89 | CN¥19.00 | n/a | 5 |
| Apr ’25 | CN¥15.75 | CN¥22.52 +43.0% | 16.4% | CN¥27.89 | CN¥19.00 | n/a | 5 |
| Mar ’25 | CN¥15.60 | CN¥27.21 +74.4% | 15.6% | CN¥34.24 | CN¥21.00 | n/a | 5 |
| Feb ’25 | CN¥14.10 | CN¥27.21 +93.0% | 15.6% | CN¥34.24 | CN¥21.00 | n/a | 5 |
| Jan ’25 | CN¥15.92 | CN¥27.21 +70.9% | 15.6% | CN¥34.24 | CN¥21.00 | n/a | 5 |
| Dec ’24 | CN¥16.66 | CN¥27.21 +63.3% | 15.6% | CN¥34.24 | CN¥21.00 | n/a | 5 |
| Nov ’24 | CN¥17.32 | CN¥27.81 +60.6% | 15.3% | CN¥34.24 | CN¥21.00 | CN¥12.71 | 5 |
| Oct ’24 | CN¥20.56 | CN¥29.38 +42.9% | 10.1% | CN¥34.24 | CN¥25.30 | CN¥12.77 | 5 |
| Sep ’24 | CN¥22.33 | CN¥29.38 +31.6% | 10.1% | CN¥34.24 | CN¥25.30 | CN¥9.97 | 5 |
| Aug ’24 | CN¥22.80 | CN¥29.38 +28.8% | 10.1% | CN¥34.24 | CN¥25.30 | CN¥11.35 | 5 |
| Jul ’24 | CN¥20.52 | CN¥30.40 +48.1% | 7.9% | CN¥34.24 | CN¥27.89 | CN¥13.02 | 4 |
| Jun ’24 | CN¥19.55 | CN¥30.40 +55.5% | 7.9% | CN¥34.24 | CN¥27.89 | CN¥14.99 | 4 |
| May ’24 | CN¥21.10 | CN¥30.27 +43.4% | 7.1% | CN¥34.24 | CN¥27.89 | CN¥15.52 | 5 |
| Apr ’24 | CN¥24.13 | CN¥30.27 +25.4% | 7.1% | CN¥34.24 | CN¥27.89 | CN¥15.75 | 5 |
| Mar ’24 | CN¥22.98 | CN¥32.73 +42.4% | 9.1% | CN¥37.57 | CN¥29.75 | CN¥15.60 | 5 |
| Feb ’24 | CN¥24.73 | CN¥32.73 +32.3% | 9.1% | CN¥37.57 | CN¥29.75 | CN¥14.10 | 5 |
| Jan ’24 | CN¥21.43 | CN¥32.73 +52.7% | 9.1% | CN¥37.57 | CN¥29.75 | CN¥15.92 | 5 |
| Dec ’23 | CN¥23.63 | CN¥31.08 +31.5% | 16.1% | CN¥37.57 | CN¥22.94 | CN¥16.66 | 5 |
| Nov ’23 | CN¥18.44 | CN¥31.08 +68.6% | 16.1% | CN¥37.57 | CN¥22.94 | CN¥17.32 | 5 |
Analyst Forecast: Target price is lower than the current share price.
Discover undervalued companies
MeiHua Holdings GroupLtd
CN¥28.8b
A synthetic biology company, provides amino acid nutrition and health solutions in China and internationally.
600873
CN¥10.09
7D
-0.4%
1Y
8.5%
Chifeng Jilong Gold MiningLtd
CN¥28.4b
Operates as a gold and non-ferrous metal mining company.
600988
CN¥17.20
7D
-0.8%
1Y
23.2%
Western MiningLtd
CN¥41.3b
Engages in the mining, smelting, and trading of metals in Mainland China and internationally.
601168
CN¥17.00
7D
-7.0%
1Y
34.4%